Comments
Loading...

Alnylam Pharmaceuticals

ALNYNASDAQ
Logo brought to you by Benzinga Data
$242.99
-2.45-1.00%
Pre-Market: 7:48 AM EDT

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock, Earnings Estimates, EPS, And Revenue

Alnylam Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 13
EPS Estimate
$-0.220
Quarterly Revenue Estimate
$578.2M
Annual Revenue
(as of Sep 30)
$2.1B

Analyze the earnings history of Alnylam Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Alnylam Pharmaceuticals (ALNY) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-31$-0.50$-0.9346.2 %
Jun 20242024-08-01$0.56$-1.08151.8 %
Mar 20242024-05-02$-0.16$-1.1886.4 %
Dec 20232024-02-15$-0.77$-1.3342.1 %

Alnylam Pharmaceuticals (ALNY) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-10-31$500.92M$533.10M-6.04 %
Jun 20242024-08-01$659.83M$444.11M48.6 %
Mar 20242024-05-02$494.33M$427.33M15.7 %
Dec 20232024-02-15$439.72M$442.90M-0.72 %

FAQ

Q

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

A

Alnylam Pharmaceuticals (ALNY) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Alnylam Pharmaceuticals (NASDAQ:ALNY)?

A

The Actual EPS was $-0.50, which beat the estimate of $-0.93.

Q

What were Alnylam Pharmaceuticals’s (NASDAQ:ALNY) revenues?

A

The Actual Revenue was $500.9M, which missed the estimate of $533.1M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch